Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Squamous Cell × tremelimumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Prostatic Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Mesothelioma 2 Lung Neoplasms 2 Liver Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Solid Tumor 1 Sarcoma, Synovial 1

Interventions

Cisplatin 24 Cetuximab 16 Radiotherapy 14 Carboplatin 13 pembrolizumab 11 Paclitaxel 9 Drug Therapy 8 Radiotherapy, Intensity-Modulated 6 Radiation 6 Fluorouracil 6 Erlotinib Hydrochloride 6 Nivolumab 5 Docetaxel 5 130-nm albumin-bound paclitaxel 5 Panitumumab 4 Chemoradiotherapy 3 Capecitabine 3 Bevacizumab 3 Albumin-Bound Paclitaxel 3 Afatinib 3 selinexor 2 figitumumab 2 Restraint, Physical 2 Radiosurgery 2 Methotrexate 2 Lapatinib 2 Everolimus 2 Esophagectomy 2 Cyclophosphamide 2 zalutumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡